The FDA recently gave accelerated approval for a new Alzheimer's drug that appears to slow cognitive decline. NBC News Senior Medical Corespondent Dr. John Torres reports on revelations of the study despite some health experts warning of various safety concerns. Jan. 6, 2023
UP NEXT
Could messaging your doctor cost you money?
02:35
How one L.A. high school uses meditation to help at-risk teens succeed
05:09
Comedian Phoebe Robinson on walking the runway for a good cause
03:52
EzriCare eyedrops recalled over link to bacterial infections
00:23
Weight loss drugs like Wegovy access limited by insurance and Medicare coverage
02:38
Stepson helps father with remarkable recovery after accident